Healthcare News

RSS

Study supports the need for improving early TB diagnosis and care in Irish prisons

Investigators from Trinity College Dublin, the Irish Mycobacteria Reference Laboratory, St James's Hospital, and the Department of Public Health HSE East believe tuberculosis (TB) care in Irish Prisons should be supported, considering the findings of their study which is published today (Tuesday, 1st June, 2021) in the International Journal of Tuberculosis and Lung Disease.

1 Jun 2021

New brain-training app helps people to change eating habits and lose weight

Using a brain-training app helps people eat less junk food and lose weight, new research suggests.

1 Jun 2021

Compelling evidence of SARS-CoV-2 exposure and neutralizing antibodies in domestic cats in Peru

Although Peru is one of the countries most affected by the pandemic, no studies had been conducted to investigate SARS-CoV-2 seroprevalence among domestic cats. Recently, researchers from Peru demonstrated the presence of neutralizing antibodies for the receptor binding-domain (RBD) of the SARS-CoV-2 spike protein in cats in Lima, Peru. The owners of the cats in the study had confirmed SARS-CoV-2 infection.

1 Jun 2021

Antibody cocktail effectively inhibits SARS-CoV-2 in the rhesus macaque model

Researchers from the US tested the prophylactic potential of a combination of 2 mAbs administered 3 or 75 days before respiratory challenge in rhesus macaques. They used the rhesus macaque model to test the added benefit of combinatory parenteral administration of 2 high-affinity anti-SARS-CoV-2 mAbs - C144-LS and C135-LS. These mAbs were developed to neutralize the virus and tweaked to improve their pharmacokinetics.

1 Jun 2021

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.

1 Jun 2021

Study offers longitudinal roadmap of immune activation and resolution in mild COVID-19

Researchers from the US recently profiled the longitudinal immune response in mild COVID-19 patients starting with early time points of 1-15 days post-infection through convalescence to over 100 days after onset of symptoms.

1 Jun 2021

VirtaMed appoints Andy Weymann, MD, MBA, to Board of Directors

June 1, 2021, Zurich, Switzerland: VirtaMed, the world leader in medical simulation training, has added Andy Weymann to its board of directors.

From VirtaMed 1 Jun 2021

New initiative to reduce treatment delays for patients with rare diseases

The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise.

1 Jun 2021

Weaker association between brain activity and cerebrospinal fluid flow increases the likelihood of Alzheimer's disease

New imaging research shows that brain activity during sleep was less connected with cerebrospinal fluid flow in patients with Alzheimer's disease.

1 Jun 2021

Researchers identify common epitopes across SARS-CoV-2 viral variants

While several COVID-19 vaccine candidates have been developed and deployed to arrest the spread of SARS-CoV-2, concern among scientists and public health authorities is mounting over the immunity escape potential of emerging viral variants. To address this problem, a group of scientists in Germany has undertaken research to identify molecular targets across viral variants to aid in the development of second and third-generation vaccines and novel therapeutics.

1 Jun 2021

Little-known illnesses turning up in Covid long-haulers

The day Dr. Elizabeth Dawson was diagnosed with covid-19 in October, she awoke feeling as if she had a bad hangover. Four months later she tested negative for the virus, but her symptoms have only worsened.

1 Jun 2021

New method helps identify rare genetic disease that affects brain development

Rare disease experts detail the first results of an unprecedented collaboration to diagnose people living with unsolved cases of rare diseases across Europe.

1 Jun 2021

How the decline in fish biodiversity is affecting human nutrition

Researchers have found that biomass compensation may impair the health of populations that depend on fish for their daily nutritional intake.

1 Jun 2021

Can depression increase the likelihood of rapid kidney function decline?

In a recent study, the presence of depressive symptoms in normally healthy individuals was found to correlate with rapid kidney function decline.

1 Jun 2021

FDA approves investigational monoclonal antibody therapy sotrovimab for COVID-19

The U.S. Food and Drug Administration (FDA) has given the green light on the investigational monoclonal antibody therapy, sotrovimab, as a coronavirus disease (COVID-19) treatment.

1 Jun 2021

Vitamin D may be ineffective in protecting against COVID-19

A study published in PLOS Medicine suggests that genetic evidence does not support vitamin D as a protective measure against COVID-19.

1 Jun 2021

Better late than never: clinical guidelines are too late to screen for prostate cancer

Men with a family history of prostate cancer may need to be screened up to 11 years before guidelines require.

1 Jun 2021

Diabetes remission diet can provide blood pressure control, reduce the need for anti-hypertensive drugs

New research has shown that if people achieve and maintain substantial weight loss to manage their type 2 diabetes, many can also effectively control their high blood pressure and stop or cut down on their anti-hypertensive medication.

31 May 2021

COVID-19 had claimed more than 3 million lives worldwide in 2020

By the end of 2020, COVID-19 had claimed the lives of more than three million people worldwide, representing 1.2 million more deaths than officially reported earlier, says a newly released report by the World Health Organization (WHO).

31 May 2021

AI models look for shortcuts that could lead to errors in diagnosis of COVID-19

Artificial intelligence promises to be a powerful tool for improving the speed and accuracy of medical decision-making to improve patient outcomes.

31 May 2021

Healthcare News

Study supports the need for improving early TB diagnosis and care in Irish prisons

New brain-training app helps people to change eating habits and lose weight

Compelling evidence of SARS-CoV-2 exposure and neutralizing antibodies in domestic cats in Peru

Antibody cocktail effectively inhibits SARS-CoV-2 in the rhesus macaque model

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

Study offers longitudinal roadmap of immune activation and resolution in mild COVID-19

VirtaMed appoints Andy Weymann, MD, MBA, to Board of Directors

New initiative to reduce treatment delays for patients with rare diseases

Weaker association between brain activity and cerebrospinal fluid flow increases the likelihood of Alzheimer's disease

Researchers identify common epitopes across SARS-CoV-2 viral variants

Little-known illnesses turning up in Covid long-haulers

New method helps identify rare genetic disease that affects brain development

How the decline in fish biodiversity is affecting human nutrition

Can depression increase the likelihood of rapid kidney function decline?

FDA approves investigational monoclonal antibody therapy sotrovimab for COVID-19

Vitamin D may be ineffective in protecting against COVID-19

Better late than never: clinical guidelines are too late to screen for prostate cancer

Diabetes remission diet can provide blood pressure control, reduce the need for anti-hypertensive drugs

COVID-19 had claimed more than 3 million lives worldwide in 2020

AI models look for shortcuts that could lead to errors in diagnosis of COVID-19

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News